Connor, Clark & Lunn Investment Management Ltd. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 167 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$712,416
+50.0%
209,534
+356.9%
0.00%
+33.3%
Q1 2023$475,058
-88.3%
45,855
+16.5%
0.00%
-88.9%
Q3 2020$4,066,000
+129.3%
39,350
+75.5%
0.03%
+107.7%
Q2 2020$1,773,000
-12.1%
22,421
-55.5%
0.01%
-23.5%
Q4 2015$2,017,000
+74.8%
50,400
+24.4%
0.02%
+88.9%
Q3 2015$1,154,000
+474.1%
40,500
+563.9%
0.01%
+350.0%
Q2 2015$201,000
-86.7%
6,100
-88.7%
0.00%
-81.8%
Q1 2014$1,506,00054,0110.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Values First Advisors, Inc. 152,699$519,1780.34%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 299,187$1,017,0000.22%
Hilltop Holdings Inc. 235,019$799,0640.09%
AIMZ Investment Advisors, LLC 51,372$174,6650.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 868,605$2,953,2570.07%
PALISADE CAPITAL MANAGEMENT, LP 509,325$1,731,7050.05%
SHERBROOKE PARK ADVISERS LLC 41,417$140,8180.04%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2,428,490$8,256,8660.03%
Y-Intercept (Hong Kong) Ltd 75,362$256,2310.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,246,020$4,236,4680.02%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders